Table 3.

MFAT and LP secretome at 3, 7, 14, and 28 days in vitro.

Analytes	3 days of culture		7 days of culture		14 days of culture		28 days of culture
	MFAT-CM	LP-CM	MFAT-CM	LP-CM	MFAT-CM	LP-CM	MFAT-CM	LP-CM
IL-1rα	55 ± 18	53 ± 17	51 ± 27	151 ± 78	121 ± 43	—	48 ± 23	—
IL-6	65 ± 23	276 ± 67	403 ± 98	3982 ± 90∗	219 ± 87∗	7 ± 5	95 ± 31	3 ± 2
IL-8	3770 ± 1245	2860 ± 890	4777 ± 1769	8108 ± 1422∗	1038 ± 432	512 ± 102	463 ± 145∗	112 ± 46
IL-12p70	—	—	—	220 ± 88	114 ± 32	—	77 ± 14	—
β-FGF	650 ± 231	518 ± 198	302 ± 96	134 ± 67	130 ± 54	154 ± 56	66 ± 25	126 ± 85
G-CSF	398 ± 123	839 ± 234	73 ± 54	238 ± 98	180 ± 38	—	—	—
GM-CSF	79 ± 32	61 ± 34	61 ± 43	73 ± 13	62 ± 25	71 ± 34	60 ± 35	—
MCP-1	317 ± 145	317 ± 78	283 ± 98	383 ± 121	351 ± 87∗	—	249 ± 124∗
PDGF-BB	47 ± 239	32 ± 16	—	—	—	—	—	—
RANTES	193 ± 87	49 ± 21	—	114 ± 33	—	—	—	—
VEGF	515 ± 145	251 ± 78	308 ± 30	1446 ± 799∗	749 ± 68∗	123 ± 87	479±39∗∗	63 ± 18
IL-2rα	—	—	—	—	52 ± 18	—	47 ± 26	—
IL-3	82 ± 43	66 ± 31	62 ± 15	81 ± 34	89 ± 25	—	75 ± 27−
IL-12p40	224 ± 56	202 ± 50	170 ± 32	191 ± 87	202 ± 46	70 ± 31	201 ± 86∗	—
IL-16	332 ± 89	124 ± 43	130 ± 56	213 ± 111	58 ± 57	—	47 ± 15	—
GROa	68 ± 22	102 ± 42	134 ± 87	787 ± 234	58 ± 32	30 ± 15	41 ± 18	—
HGF	12003 ± 4657	7315 ± 2354	5490 ± 1677	5584 ± 1989	13442±3687∗∗	772 ± 232	9839±2341∗∗	239 ± 97
LIF	56 ± 16	56 ± 17	61 ± 23	177 ± 89	32 ± 13	—	17 ± 3	—
M-CSF	252 ± 69	116 ± 43	271 ± 99	354 ± 143	124 ± 65	—	60 ± 9	—
MIF	7912 ± 2368	10086 ± 2899	4565 ± 908	3382 ± 970	7915±768∗∗	1407 ± 398	6430±11387∗∗	127 ± 54
MIG	925 ± 329	1323 ± 675	1390 ± 455	4048 ± 1324	195 ± 76∗	—	51 ± 24	—
SCF	71 ± 45	114 ± 65	166 ± 77	205 ± 54	41 ± 32	—	22 ± 9	—
SCGF-β	5591 ± 1457	1343 ± 630	1203 ± 544	2492 ± 545	5699±1875∗∗	201 ± 54	4560±799∗∗	—
SDF-1	72 ± 21	82 ± 29	71 ± 32	96 ± 29	106 ± 51	62 ± 32	99 ± 30	—
TRAIL	85 ± 47	46 ± 12	37 ± 11	57 ± 21	41 ± 10	—	—	—
Total	33, 759 ± 6567	26, 279 ± 5688	20, 039 ± 4387	32, 872 ± 9854∗	31, 059±8975∗∗	3, 329 ± 1254	23, 057±6590∗∗	706 ± 154

^∗ p < 0.05; ^∗∗p < 0.01 MFAT-CM vs. LP-CM.